Celadon Pharmaceuticals PLC (GB:CEL) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Celadon Pharmaceuticals PLC is navigating financial delays, with partial funding received from a committed equity fundraise and a credit facility drawdown. The UK-based cannabis medicine developer is managing a tight cash flow situation, with current funds at £210k, and is in talks with potential lenders for substantial long-term debt facilities. The company remains optimistic about receiving the outstanding funds and securing its long-term financial stability.
For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.
